CASI Pharmaceuticals Holdings Inc. navigates market challenges and opportunities in the healthcare sector, positioning itself for future growth through innovation and strategic partnerships.

CASI Pharmaceuticals Holdings Inc is a healthcare company focused on developing and commercializing innovative therapeutics, with a strong global presence and a robust pipeline of potential treatments.

CASI Pharmaceuticals Holdings Inc. has announced a major divestiture of its Chinese assets to Kaixin Pharmaceuticals Inc. for approximately $20 million, aiming to streamline operations and focus on core competencies.